RTS,S Malaria Vaccine Declared Safe: Ebenezer Adangabe Urges Parents to Join the Fight Against Malaria
Malaria remains one of the most persistent public health challenges in Ghana, especially among children under five. But a new chapter is unfolding in the fight against this deadly disease, thanks to the introduction of the RTS,S malaria vaccine—a breakthrough with the potential to save thousands of lives.
Ebenezer Adangabe, Director of Research at the Ghana Health Service (GHS) Navrongo Division, has assured the public of the vaccine’s safety and urged parents to embrace it as a vital step toward malaria eradication. Speaking during a community engagement session in Navrongo, Adangabe stressed that the vaccine has passed rigorous clinical trials and has been approved by global health authorities including the World Health Organization (WHO).
“The RTS,S malaria vaccine is safe and effective. It offers real hope to families in our communities, particularly in areas like Navrongo where malaria continues to be a major threat. I strongly encourage all parents to ensure their children are vaccinated. This is a critical move toward a malaria-free future,” he emphasized.
The rollout of the RTS,S vaccine in Ghana is a landmark achievement and forms part of the national strategy to reduce malaria-related deaths and severe illnesses. The vaccine is being administered to children starting at six months of age and is expected to significantly lower the incidence of severe malaria cases.
Ebenezer Adangabe also called for broad community participation in the vaccination drive, urging traditional leaders, religious groups, teachers, and local influencers to help spread accurate information and dispel myths about the vaccine.
“The fight against malaria is not just the responsibility of health workers—it involves everyone. When we come together as a community, we can protect our children and future generations from this deadly disease,” he added.
The Navrongo Health Research Centre, a leader in malaria research for decades, continues to support these efforts through monitoring, education, and evidence-based recommendations. The centre remains committed to ensuring that the vaccine rollout is smooth, inclusive, and impactful.
Parents and caregivers in the Upper East Region are encouraged to visit the nearest health facility for more information and to make sure their children receive all recommended doses of the RTS,S vaccine.
With strong leadership, scientific innovation, and community action, Ghana is moving closer to its goal of eliminating malaria—and everyone has a role to play.
